Vincenzo Brescia Morra

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis

Roberta Lanzillo, Gilda Cennamo, Chiara Criscuolo et al. · Multiple Sclerosis Journal · 2017 · 125 citations

Medicine, Neurology, Ophthalmology +17

Safety and efficacy of natalizumab in children with multiple sclerosis

Angelo Ghezzi, Carlo Pozzilli, Luigi Grimaldi et al. · Neurology · 2010 · 93 citations

Medicine, Neurology, Pharmacotherapy +12

Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis

Maria Pia Amato, Mattia Fonderico, Emilio Portaccio et al. · Brain · 2020 · 90 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +14

Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis

Luigi Lavorgna, Manuela De Stefano, Maddalena Sparaco et al. · Multiple Sclerosis and Related Disorders · 2018 · 79 citations · Full text

Social Sciences, Communication, Health Communication +16